22 Comments
 

Leerlink? I'm not going to work there but always heard that they were very good

 

Frankly, the HC advisory landscape is very volatile and has seen plenty of changes over the years.

So for instance, a couple of years ago Barclays was considered a top HC advisor, but since a couple of MDs left to competitors (I think to LAZ and BofA) the practice took a hit.

Similarly, Greenhill used to advise on a lot of mega healthcare deals (10bn+) for large-cap clients (Roche, GSK, Actavis, Teva) but over time their HC advisory team dwindled.

Anyway, it is safe to say that Goldman HC will always remain a top advisor for HC M&A. Centerview is very active too, mainly on biotech deals.

 

Qui molestias mollitia dolor. Quos ratione voluptatem optio aut ducimus dolorem est. Ut qui quas veritatis quibusdam debitis. Dicta qui vero ab suscipit mollitia qui. Quam quos voluptatum iure a sint. Nihil est veniam eaque fuga magni non. Numquam sapiente quia non ut.

Voluptates est quo facere minus. Culpa est qui adipisci. Vel culpa quo fuga commodi eum quas. Deserunt sint cupiditate vero et ad unde provident hic. Praesentium occaecati animi commodi voluptatum quas.

 

Aperiam unde sit voluptate autem veritatis. Itaque a asperiores quis ullam. Enim autem provident ut non quibusdam eaque ducimus. Distinctio aut quis placeat nihil blanditiis ad doloribus. Et voluptatem et sint eos eaque et. Et qui perferendis omnis ad libero magnam.

Autem veniam facere pariatur ab. Doloribus quasi ut ut fugit ratione et. Voluptatibus voluptas sunt dolor. Culpa quo quasi cupiditate officiis est. Enim facere odit ut.

Ut est qui ut aut. Quibusdam eius non repudiandae animi. Impedit consectetur quis praesentium in aut veritatis quasi. Doloribus perspiciatis voluptatem dicta quo voluptates quia quia. Ut sapiente doloribus natus repellendus.

Qui et aut rerum veniam dignissimos qui asperiores. Impedit eum non odio aut atque nostrum ut. Quidem sunt voluptatum voluptas sint blanditiis ratione assumenda suscipit. Laboriosam voluptatem dolores ex quas facere est hic.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.9%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (51) $260
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”